Isabelle Suarez
Overview
Explore the profile of Isabelle Suarez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klingmuller A, Feldmann M, Rohr S, Helmhold L, Junker L, Scherer M, et al.
Infection
. 2025 Mar;
PMID: 40067569
Purpose: Tuberculosis (TB) remains a leading cause of morbidity and mortality, with 1.3 million deaths in 2022. Extrapulmonary tuberculosis (EPTB) accounts for approximately 20% of all TB cases. We assessed...
2.
Weber S, Wolf P, Wetzstein N, Kupper-Tetzel C, Vehreschild M, Suarez I, et al.
Open Forum Infect Dis
. 2024 Dec;
11(12):ofae651.
PMID: 39691283
Background: There is limited evidence on point-of-care ultrasound for tuberculosis (TB), but studies suggest high sensitivity, especially for lung ultrasound (LUS). However, insufficient data are available on specificity of the...
3.
Augustin M, Horn C, Ercanoglu M, Bondet V, de Silva U, Suarez I, et al.
Biomedicines
. 2024 Oct;
12(10).
PMID: 39457626
Background: Gastrointestinal mucosal damage due to human immunodeficiency virus (HIV) infection leads to microbial translocation and immune activation, contributing to the development of non-infectious comorbidities (NICM) in people living with...
4.
Johansen I, Roen A, Kraef C, Martin-Iguacel R, Nemeth J, Fenner L, et al.
Int J Infect Dis
. 2024 Aug;
147:107199.
PMID: 39142437
Objectives: Tuberculosis (TB) risk after initiation of antiretroviral treatment (ART) is not well described in a European setting, with an average TB incidence of 25/10 in the background population. Methods:...
5.
Friesen I, Dreyer V, Klingmuller A, Zuber S, Hoffmann A, Suarez I, et al.
Euro Surveill
. 2024 Jul;
29(28).
PMID: 38994601
This report documents the case of a Ukrainian patient infected with an extensively drug-resistant (XDR) lineage 2 strain harbouring the rifampicin resistance mutation RpoB I491F. This mutation is not detected...
6.
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, et al.
Clin Infect Dis
. 2024 Apr;
79(5):1242-1257.
PMID: 38663013
Background: Mortality among people with human immunodeficiency virus (HIV) declined with the introduction of combination antiretroviral therapy. We investigated trends in mortality in people with HIV from 1999 through 2020....
7.
Dewald F, Steger G, Fish I, Torre-Lage I, Hellriegel C, Milz E, et al.
Pediatrics
. 2024 Apr;
153(5).
PMID: 38596855
Background And Objectives: Test-to-stay concepts apply serial testing of children in daycare after exposure to SARS-CoV-2 without use of quarantine. This study aims to assess the safety of a test-to-stay...
8.
Suarez I, Rauschning D, Schuller C, Hagemeier A, Stecher M, Lehmann C, et al.
Infection
. 2024 Mar;
52(4):1439-1448.
PMID: 38492196
Purpose: The risk of developing active tuberculosis (TB) is considerably increased in people living with HIV/AIDS (PLWH). However, incidence of HIV/TB coinfection is difficult to assess as surveillance data are...
9.
Schmidt-Hellerau K, Baade N, Gunther M, Scholten N, Lindemann C, Leisse C, et al.
Infection
. 2024 Mar;
52(4):1407-1414.
PMID: 38478255
Purpose: Outpatient parenteral antimicrobial therapy (OPAT) offers several key advantages, including enhanced patient quality of life, reduced healthcare costs, and a potential reduction of nosocomial infections. It is acknowledged for...
10.
Schommers P, Kim D, Schlotz M, Kreer C, Eggeling R, Hake A, et al.
Nat Med
. 2023 Nov;
29(11):2763-2774.
PMID: 37957379
Human immunodeficiency virus type 1 (HIV-1)-neutralizing antibodies (nAbs) that prevent infection are the main goal of HIV vaccine discovery. But as no nAb-eliciting vaccines are yet available, only data from...